Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Recruiting2
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

completed125%
terminated125%
recruiting250%

Recent Activity

2 active trials
Showing 4 of 4
recruiting

International (Pediatric) Peritoneal Biobank

NCT01893710
terminatednot_applicable

Validation of Alveolar Probe-based Confocal Laser Endomicroscopy Descriptors in Diffuse Parenchymal Lung Diseases

NCT02961335
completedphase_3

Interest of in Situ Terlipressin Administration Before the Realisation of Bronchial Biopsy

NCT02970175
recruitingnot_applicable

Mucosal IgE to Improve Diagnosis of Food Allergy and Food Hypersensitivity

NCT05259826

Clinical Trials (4)

Showing 4 of 4 trials
NCT01893710

International (Pediatric) Peritoneal Biobank

Recruiting
NCT02961335Not Applicable

Validation of Alveolar Probe-based Confocal Laser Endomicroscopy Descriptors in Diffuse Parenchymal Lung Diseases

Terminated
NCT02970175Phase 3

Interest of in Situ Terlipressin Administration Before the Realisation of Bronchial Biopsy

Completed
NCT05259826Not Applicable

Mucosal IgE to Improve Diagnosis of Food Allergy and Food Hypersensitivity

Recruiting

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4